Global Respiratory Pathogen Kit Market Research Report 2023

Publication ID:

PB504245051

Publication Date:

May 22, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Respiratory Pathogen Kit market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Respiratory Pathogen Kit is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Respiratory Pathogen Kit is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Respiratory Pathogen Kit include Roche, TRUPCR, Illumina, SML Genetree, Luminex, EUROIMMUN Medizinische Labordiagnostika AG, Autobio Diagnostics, Sansure Biotech and Wuhan Zhongzhi Biotechnologies, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Respiratory Pathogen Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Pathogen Kit.
The Respiratory Pathogen Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Respiratory Pathogen Kit market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Pathogen Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Roche
TRUPCR
Illumina
SML Genetree
Luminex
EUROIMMUN Medizinische Labordiagnostika AG
Autobio Diagnostics
Sansure Biotech
Wuhan Zhongzhi Biotechnologies
Ningbo Health Gene Technologies
Shanghai Biogerm Medical Technology
Beijing Applied Biological Technologies
Shanghai Geneodx Biotechnology
Beijing Baicare Biotechnology
Segment by Type
Six Respiratory Pathogen Nucleic Acid Detection Kits
Seven Respiratory Pathogen Nucleic Acid Detection Kit
Eight Respiratory Pathogen Nucleic Acid Detection Kits
Others
Segment by Application
Clinical Diagnosis
Research Diagnosis
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Respiratory Pathogen Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Respiratory Pathogen Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Respiratory Pathogen Kit Market Overview
1.1 Product Overview and Scope of Respiratory Pathogen Kit
1.2 Respiratory Pathogen Kit Segment by Type
1.2.1 Global Respiratory Pathogen Kit Market Value Comparison by Type (2023-2029)
1.2.2 Six Respiratory Pathogen Nucleic Acid Detection Kits
1.2.3 Seven Respiratory Pathogen Nucleic Acid Detection Kit
1.2.4 Eight Respiratory Pathogen Nucleic Acid Detection Kits
1.2.5 Others
1.3 Respiratory Pathogen Kit Segment by Application
1.3.1 Global Respiratory Pathogen Kit Market Value by Application: (2023-2029)
1.3.2 Clinical Diagnosis
1.3.3 Research Diagnosis
1.4 Global Respiratory Pathogen Kit Market Size Estimates and Forecasts
1.4.1 Global Respiratory Pathogen Kit Revenue 2018-2029
1.4.2 Global Respiratory Pathogen Kit Sales 2018-2029
1.4.3 Global Respiratory Pathogen Kit Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Respiratory Pathogen Kit Market Competition by Manufacturers
2.1 Global Respiratory Pathogen Kit Sales Market Share by Manufacturers (2018-2023)
2.2 Global Respiratory Pathogen Kit Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Respiratory Pathogen Kit Average Price by Manufacturers (2018-2023)
2.4 Global Respiratory Pathogen Kit Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Respiratory Pathogen Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Respiratory Pathogen Kit, Product Type & Application
2.7 Respiratory Pathogen Kit Market Competitive Situation and Trends
2.7.1 Respiratory Pathogen Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Respiratory Pathogen Kit Players Market Share by Revenue
2.7.3 Global Respiratory Pathogen Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Respiratory Pathogen Kit Retrospective Market Scenario by Region
3.1 Global Respiratory Pathogen Kit Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Respiratory Pathogen Kit Global Respiratory Pathogen Kit Sales by Region: 2018-2029
3.2.1 Global Respiratory Pathogen Kit Sales by Region: 2018-2023
3.2.2 Global Respiratory Pathogen Kit Sales by Region: 2024-2029
3.3 Global Respiratory Pathogen Kit Global Respiratory Pathogen Kit Revenue by Region: 2018-2029
3.3.1 Global Respiratory Pathogen Kit Revenue by Region: 2018-2023
3.3.2 Global Respiratory Pathogen Kit Revenue by Region: 2024-2029
3.4 North America Respiratory Pathogen Kit Market Facts & Figures by Country
3.4.1 North America Respiratory Pathogen Kit Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Respiratory Pathogen Kit Sales by Country (2018-2029)
3.4.3 North America Respiratory Pathogen Kit Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Respiratory Pathogen Kit Market Facts & Figures by Country
3.5.1 Europe Respiratory Pathogen Kit Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Respiratory Pathogen Kit Sales by Country (2018-2029)
3.5.3 Europe Respiratory Pathogen Kit Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Respiratory Pathogen Kit Market Facts & Figures by Country
3.6.1 Asia Pacific Respiratory Pathogen Kit Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Respiratory Pathogen Kit Sales by Country (2018-2029)
3.6.3 Asia Pacific Respiratory Pathogen Kit Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Respiratory Pathogen Kit Market Facts & Figures by Country
3.7.1 Latin America Respiratory Pathogen Kit Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Respiratory Pathogen Kit Sales by Country (2018-2029)
3.7.3 Latin America Respiratory Pathogen Kit Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Respiratory Pathogen Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Respiratory Pathogen Kit Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Respiratory Pathogen Kit Sales by Country (2018-2029)
3.8.3 Middle East and Africa Respiratory Pathogen Kit Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Respiratory Pathogen Kit Sales by Type (2018-2029)
4.1.1 Global Respiratory Pathogen Kit Sales by Type (2018-2023)
4.1.2 Global Respiratory Pathogen Kit Sales by Type (2024-2029)
4.1.3 Global Respiratory Pathogen Kit Sales Market Share by Type (2018-2029)
4.2 Global Respiratory Pathogen Kit Revenue by Type (2018-2029)
4.2.1 Global Respiratory Pathogen Kit Revenue by Type (2018-2023)
4.2.2 Global Respiratory Pathogen Kit Revenue by Type (2024-2029)
4.2.3 Global Respiratory Pathogen Kit Revenue Market Share by Type (2018-2029)
4.3 Global Respiratory Pathogen Kit Price by Type (2018-2029)
5 Segment by Application
5.1 Global Respiratory Pathogen Kit Sales by Application (2018-2029)
5.1.1 Global Respiratory Pathogen Kit Sales by Application (2018-2023)
5.1.2 Global Respiratory Pathogen Kit Sales by Application (2024-2029)
5.1.3 Global Respiratory Pathogen Kit Sales Market Share by Application (2018-2029)
5.2 Global Respiratory Pathogen Kit Revenue by Application (2018-2029)
5.2.1 Global Respiratory Pathogen Kit Revenue by Application (2018-2023)
5.2.2 Global Respiratory Pathogen Kit Revenue by Application (2024-2029)
5.2.3 Global Respiratory Pathogen Kit Revenue Market Share by Application (2018-2029)
5.3 Global Respiratory Pathogen Kit Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Respiratory Pathogen Kit Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 TRUPCR
6.2.1 TRUPCR Corporation Information
6.2.2 TRUPCR Description and Business Overview
6.2.3 TRUPCR Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.2.4 TRUPCR Respiratory Pathogen Kit Product Portfolio
6.2.5 TRUPCR Recent Developments/Updates
6.3 Illumina
6.3.1 Illumina Corporation Information
6.3.2 Illumina Description and Business Overview
6.3.3 Illumina Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Illumina Respiratory Pathogen Kit Product Portfolio
6.3.5 Illumina Recent Developments/Updates
6.4 SML Genetree
6.4.1 SML Genetree Corporation Information
6.4.2 SML Genetree Description and Business Overview
6.4.3 SML Genetree Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SML Genetree Respiratory Pathogen Kit Product Portfolio
6.4.5 SML Genetree Recent Developments/Updates
6.5 Luminex
6.5.1 Luminex Corporation Information
6.5.2 Luminex Description and Business Overview
6.5.3 Luminex Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Luminex Respiratory Pathogen Kit Product Portfolio
6.5.5 Luminex Recent Developments/Updates
6.6 EUROIMMUN Medizinische Labordiagnostika AG
6.6.1 EUROIMMUN Medizinische Labordiagnostika AG Corporation Information
6.6.2 EUROIMMUN Medizinische Labordiagnostika AG Description and Business Overview
6.6.3 EUROIMMUN Medizinische Labordiagnostika AG Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.6.4 EUROIMMUN Medizinische Labordiagnostika AG Respiratory Pathogen Kit Product Portfolio
6.6.5 EUROIMMUN Medizinische Labordiagnostika AG Recent Developments/Updates
6.7 Autobio Diagnostics
6.6.1 Autobio Diagnostics Corporation Information
6.6.2 Autobio Diagnostics Description and Business Overview
6.6.3 Autobio Diagnostics Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Autobio Diagnostics Respiratory Pathogen Kit Product Portfolio
6.7.5 Autobio Diagnostics Recent Developments/Updates
6.8 Sansure Biotech
6.8.1 Sansure Biotech Corporation Information
6.8.2 Sansure Biotech Description and Business Overview
6.8.3 Sansure Biotech Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sansure Biotech Respiratory Pathogen Kit Product Portfolio
6.8.5 Sansure Biotech Recent Developments/Updates
6.9 Wuhan Zhongzhi Biotechnologies
6.9.1 Wuhan Zhongzhi Biotechnologies Corporation Information
6.9.2 Wuhan Zhongzhi Biotechnologies Description and Business Overview
6.9.3 Wuhan Zhongzhi Biotechnologies Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Wuhan Zhongzhi Biotechnologies Respiratory Pathogen Kit Product Portfolio
6.9.5 Wuhan Zhongzhi Biotechnologies Recent Developments/Updates
6.10 Ningbo Health Gene Technologies
6.10.1 Ningbo Health Gene Technologies Corporation Information
6.10.2 Ningbo Health Gene Technologies Description and Business Overview
6.10.3 Ningbo Health Gene Technologies Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Ningbo Health Gene Technologies Respiratory Pathogen Kit Product Portfolio
6.10.5 Ningbo Health Gene Technologies Recent Developments/Updates
6.11 Shanghai Biogerm Medical Technology
6.11.1 Shanghai Biogerm Medical Technology Corporation Information
6.11.2 Shanghai Biogerm Medical Technology Respiratory Pathogen Kit Description and Business Overview
6.11.3 Shanghai Biogerm Medical Technology Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shanghai Biogerm Medical Technology Respiratory Pathogen Kit Product Portfolio
6.11.5 Shanghai Biogerm Medical Technology Recent Developments/Updates
6.12 Beijing Applied Biological Technologies
6.12.1 Beijing Applied Biological Technologies Corporation Information
6.12.2 Beijing Applied Biological Technologies Respiratory Pathogen Kit Description and Business Overview
6.12.3 Beijing Applied Biological Technologies Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Beijing Applied Biological Technologies Respiratory Pathogen Kit Product Portfolio
6.12.5 Beijing Applied Biological Technologies Recent Developments/Updates
6.13 Shanghai Geneodx Biotechnology
6.13.1 Shanghai Geneodx Biotechnology Corporation Information
6.13.2 Shanghai Geneodx Biotechnology Respiratory Pathogen Kit Description and Business Overview
6.13.3 Shanghai Geneodx Biotechnology Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shanghai Geneodx Biotechnology Respiratory Pathogen Kit Product Portfolio
6.13.5 Shanghai Geneodx Biotechnology Recent Developments/Updates
6.14 Beijing Baicare Biotechnology
6.14.1 Beijing Baicare Biotechnology Corporation Information
6.14.2 Beijing Baicare Biotechnology Respiratory Pathogen Kit Description and Business Overview
6.14.3 Beijing Baicare Biotechnology Respiratory Pathogen Kit Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Beijing Baicare Biotechnology Respiratory Pathogen Kit Product Portfolio
6.14.5 Beijing Baicare Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Respiratory Pathogen Kit Industry Chain Analysis
7.2 Respiratory Pathogen Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Respiratory Pathogen Kit Production Mode & Process
7.4 Respiratory Pathogen Kit Sales and Marketing
7.4.1 Respiratory Pathogen Kit Sales Channels
7.4.2 Respiratory Pathogen Kit Distributors
7.5 Respiratory Pathogen Kit Customers
8 Respiratory Pathogen Kit Market Dynamics
8.1 Respiratory Pathogen Kit Industry Trends
8.2 Respiratory Pathogen Kit Market Drivers
8.3 Respiratory Pathogen Kit Market Challenges
8.4 Respiratory Pathogen Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Roche
TRUPCR
Illumina
SML Genetree
Luminex
EUROIMMUN Medizinische Labordiagnostika AG
Autobio Diagnostics
Sansure Biotech
Wuhan Zhongzhi Biotechnologies
Ningbo Health Gene Technologies
Shanghai Biogerm Medical Technology
Beijing Applied Biological Technologies
Shanghai Geneodx Biotechnology
Beijing Baicare Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂